These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6409052)

  • 1. [Mitomycin C: current status of knowledge and use in laryngeal tumors].
    Giorgi G; Bertelli E; Salvini M; Aragona P
    Arch Sci Med (Torino); 1983; 140(1):45-50. PubMed ID: 6409052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase II study of Mitomycin C in refractory adcvanced breast cancer. A multi-centre pilot study.
    van Oosterom AT; Powles TJ; Hamersma E; Smith IE; Engelsman E
    Eur J Cancer (1965); 1980; Suppl 1():275-6. PubMed ID: 6797825
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical study of 47 patients with stomach cancer treated with mitomycin C].
    Paolucci R
    Cancro; 1971; 24(3):153-9. PubMed ID: 4949673
    [No Abstract]   [Full Text] [Related]  

  • 4. [Influence of family history, irradiation and anti-cancer drug (mitomycin C) on the occurrence of multiple primary neoplasms in breast carcinoma patients].
    Yoshimoto M; Sakamoto G; Sugano H; Kasumi F; Fukami A; Kuno K
    Gan No Rinsho; 1984 Sep; 30(11):1361-8. PubMed ID: 6438367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic potential of monoalkylation products between mitomycins and DNA: studies of decarbamoyl mitomycin C in wild-type and repair-deficient cell lines.
    Kim SY; Rockwell S
    Oncol Res; 1995; 7(5):39-47. PubMed ID: 8534933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxic potential of monoalkylation products between mitomycins and DNA: studies of decarbamoyl mitomycin C in wild-type and repair-deficient cell lines.
    Rockwell S; Kim SY
    Oncol Res; 1995; 7(1):39-47. PubMed ID: 7549043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Phase II study of KW 2083 [7-N-(p-hydroxyphenyl)-mitomycin C] in patients with various cancers].
    Nishi I; Yokoyama T; Nakao I; Harashima S; Ohashi Y; Kanko T; Saito T
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2513-9. PubMed ID: 6508315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug responses of S-180 tumours in syngeneic and xenogeneic hosts.
    Chowdhury T; Lahiri T
    Indian J Exp Biol; 1986 Feb; 24(2):81-4. PubMed ID: 3089929
    [No Abstract]   [Full Text] [Related]  

  • 9. [Phase I study of KW2083 7-N-(p-hydroxyphenyl) mitomycin C].
    Gan To Kagaku Ryoho; 1982 Oct; 9(10):1844-50. PubMed ID: 7184379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic use of mitomycin C in bladder cancer.
    Denis L
    Prog Clin Biol Res; 1984; 162B():113-22. PubMed ID: 6438638
    [No Abstract]   [Full Text] [Related]  

  • 11. [Phase I-II study of 7-N-(P-hydroxyphenyl)-mitomycin C (KW2083, M83)].
    Meguro S; Nagata T; Yokoyama K; Chinen T; Kobayashi T; Yamazaki H; Kuraishi Y; Ichiba ; Abe M; Isogai Y
    Gan To Kagaku Ryoho; 1984 Sep; 11(9):1818-22. PubMed ID: 6476844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitomycin C in the treatment of gastrointestinal tumours: recent data and perspectives.
    Hofheinz RD; Beyer U; Al-Batran SE; Hartmann JT
    Onkologie; 2008 May; 31(5):271-81. PubMed ID: 18497518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitomycin C: a clinical update.
    Bradner WT
    Cancer Treat Rev; 2001 Feb; 27(1):35-50. PubMed ID: 11237776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experimental hyperthermo-chemotherapy for human gastric carcinoma transplanted in the nude mice].
    Fujimoto S; Shrestha RD; Miyazaki M; Endoh F; Shimura T; Sugasawa H; Takahashi O; Kawata S; Ohta M; Kurihara M
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2724-8. PubMed ID: 6439123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitomycin C: a prototype bioreductive agent.
    Sartorelli AC; Hodnick WF; Belcourt MF; Tomasz M; Haffty B; Fischer JJ; Rockwell S
    Oncol Res; 1994; 6(10-11):501-8. PubMed ID: 7620218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitomycins.
    Verweij J
    Cancer Chemother Biol Response Modif; 1996; 16():48-56. PubMed ID: 8639396
    [No Abstract]   [Full Text] [Related]  

  • 17. [Local mitomycin-C therapy of infiltrating bladder cancer].
    Erdmann WD; Harzmann R; Flüchter SH; Bichler KH
    Fortschr Med; 1984 Aug; 102(29-30):767-71. PubMed ID: 6437950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitomycin C.
    Verweij J; Pinedo HM
    Cancer Chemother Biol Response Modif; 1990; 11():67-73. PubMed ID: 2121210
    [No Abstract]   [Full Text] [Related]  

  • 19. Mitomycin-C therapy in advanced gastrointestinal malignant tumours.
    Vaidya MP; Prasad CN; Roy SK; Singh HN
    Indian J Cancer; 1974 Sep; 11(3):255-61. PubMed ID: 4140845
    [No Abstract]   [Full Text] [Related]  

  • 20. Hematologic toxicity of mitomycin-c (MMC) administered every three weeks in monochemotherapy of patients with solid tumors.
    Jirillo A; Demicheli R; Bonciarelli G; Lonardi F; Balli M
    Haematologica; 1987; 72(4):376-7. PubMed ID: 3117643
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.